ArticleEmerging infectious diseases2025
Differences in Lyme Disease Diagnosis among Medicaid and Medicare Beneficiaries, United States, 2016-2021.
Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ticks: Biology, Habitat, Threats and Protection Methods.Biology · 2026Review
- Lyme Disease and Health Care Costs.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lyme disease is the most common vectorborne disease in the United States. Evidence suggests that persons from racial and ethnic minority groups experience more severe disease. We used a claims-based algorithm on data from 16 jurisdictions with high Lyme disease incidence to identify cases among 4 populations: Medicaid beneficiaries <18 and >19 years of age, and Medicare fee-for-service beneficiaries <65 and >65 years of age. We calculated the prevalence of disseminated disease, hospitalization, and other clinical and epidemiologic parameters by race and ethnicity. We found that non-White persons were more likely than White persons to be female, hospitalized at diagnosis, diagnosed outside of primary care, diagnosed outside of the peak months for Lyme disease transmission, and have disseminated disease. Those data illustrate differences in Lyme disease by race and ethnicity and suggest possible differences across other sociodemographic characteristics. Additional prevention methods are needed to reduce differences in Lyme disease recognition and severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.